TD Cowen names Kiniksa Pharmaceuticals top pick with $115 price target
KNSA Kiniksa Pharmaceuticals International Plc
$93.54 -1.59%
View chart & analysis → - 1TD Cowen identified Kiniksa Pharmaceuticals as a unique opportunity in the pharmaceutical sector and named it a top pick.
- 2A price target of $115 was set for Kiniksa Pharmaceuticals.
- 3Arcalyst recorded a 23% penetration rate among approximately 14,000 patients in the U.S. estimated to have recurrent pericarditis.
So what's the key point?
Experts have selected Kiniksa Pharmaceuticals as their top recommended company. With the company's drug being used by 23 percent of patients, the stock price is expected to reach $115.
Source Investing.com · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.